Cookies and the protection of your data

We use cookies to improve the functionality of the website, to offer you a better website experience and to provide social media features. You give your consent by clicking on “Accept all Cookies” or as part of your individual settings. Please find detailed information on the use of cookies on this website in our Data Privacy Statement.

Functional Cookies

These cookies are necessary for the operation of the site and enable security-relevant functions. In addition, we determine whether you want to remain logged in and to make our services available to you when you change between this and other websites.

Statistical Cookies

These cookies are used for analyzing user behavior on our website with the aim of improving user navigation. All data collected is evaluated anonymously. Further information is available on our data protection site.

Marketing Cookies

These cookies are used to deliver relevant advertising or to limit how many times you see an ad. Marketing cookies can share that information with the advertiser (third-party cookies). The legal basis for the data processing is the consent of the user.

Inspire – The Long COVID Rehabilitation Platform
Inspire – The Long COVID Rehabilitation Platform
Inspire – The Long COVID Rehabilitation Platform
Inspire – The Long COVID Rehabilitation Platform
Inspire – The Long COVID Rehabilitation Platform
Inspire – The Long COVID Rehabilitation Platform
Inspire – The Long COVID Rehabilitation Platform
Inspire – The Long COVID Rehabilitation Platform
2023

Share:

Inspire – The Long COVID Rehabilitation Platform

Mobile App & accessory product

Crux Product Design

Inspire is a unique rehabilitation platform concept designed to aid in the clinical diagnosis of long COVID. It supports rehabilitation by tracking the evolution of the user’s symptoms, collecting consistent data and providing a community of knowledge-sharing between patients and researchers. Tracking the evolution of the symptoms is vital to assess its impact on individuals, to build a better understanding amongst researchers to provide timely and accurate treatments. The platform empowers users to take an active role in each others’ recovery by reporting the evolution of their symptoms, enabling researchers to analyse this valuable data.

Date of Launch
2023
Development Time
up to 12 Month
Target Regions
North America, South America, Africa, Asia, Australia / Oceania, Europe
Target Groups
Consumers / Users

RELATED PROJECTS